Arqule Inc's ability to collect accounts receivable sequentially worsen to 1.65, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Arqule Inc's Accounts Receivable average collection period in the Sep 30 2019 quarter, has increased to 221 days, from 164 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 537 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 3628 to 3689.

What is Receivable Turnover Ratio?
What is Arqule Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARQL Receivables Turnover Ratio	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter
Y / Y Receivable Change	-86.35 %	-54.5 %	-	-	-
Y / Y Revenue Change	-95.82 %	-97.95 %	-67.5 %	-	-
Receivable Turnover Ratio (TTM)	1.65	2.23	4.87	6.62	9.52
ARQL's Total Ranking	# 3689	# 3628	# 879	# 3659	# 0
Accounts Receivable average collection period days	222	164	75	55	38
Seq. Receivable Change	-39.72 %	-56.06 %	-44.85 %	-6.51 %	100.85 %
Seq. Revenue Change	-25.98 %	-79.11 %	-54.27 %	-40.93 %	-63.67 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 216
Healthcare Sector	# 538
Overall Market	# 3689

Receivable Turnover Ratio Statistics
High	Average	Low
6.62	3.84	1.65
(Dec 31 2018)		(Sep 30 2019)

ARQL Company Profile • Back to ARQL Efficiency Comparisons • Compare ARQL Receivables Turnover Ratio to its Competitors

Financial Statements
Arqule Inc's Accounts Receivable	$ 1 Millions	Visit ARQL's Balance sheet
Arqule Inc's Sales TTM	$ 5 Millions	Visit ARQL's Income Statement
Sources of ARQL's Revenues		Visit ARQL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARQL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARQL's Growth Rates	ARQL's Roa	ARQL's Inventory Turnover Ratio	ARQL's Dividend Comparisons
ARQL's Profitability Ratios	ARQL's Roi	ARQL's Asset Turnover Ratio	ARQL's Dividend Growth
ARQL's Valuation Ratios	ARQL's Roe	ARQL's Financial Strength Ratios	ARQL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2019	Receivable at quarter ending Sep 30 2019
Seres Therapeutics Inc	15.02	$ 37.512 Millions	$ 2.497 Millions
Mannkind Corporation	14.98	$ 63.076 Millions	$ 4.211 Millions
Kyntra Bio Inc	14.96	$ 356.657 Millions	$ 23.846 Millions
Ainos Inc	14.72	$ 0.015 Millions	$ 0.001 Millions
Plx Pharma Inc	14.55	$ 0.829 Millions	$ 0.057 Millions
Corcept Therapeutics Inc	14.45	$ 285.422 Millions	$ 19.746 Millions
Jrsis Health Care Corp	14.41	$ 30.719 Millions	$ 2.132 Millions
Neurometrix Inc	13.67	$ 11.294 Millions	$ 0.826 Millions
Musclepharm Corporation	13.63	$ 82.413 Millions	$ 6.048 Millions
Verastem Inc	13.51	$ 15.049 Millions	$ 1.114 Millions
Regeneron Pharmaceuticals Inc	13.46	$ 7,621.697 Millions	$ 566.075 Millions
Bespoke Extracts Inc	13.03	$ 0.062 Millions	$ 0.005 Millions
Emmaus Life Sciences Inc	12.96	$ 7.458 Millions	$ 0.575 Millions
Otonomy Inc	12.83	$ 0.715 Millions	$ 0.056 Millions
Reflect Scientific Inc	12.57	$ 1.410 Millions	$ 0.112 Millions
Parallax Health Sciences Inc	12.51	$ 0.079 Millions	$ 0.006 Millions
Tvardi Therapeutics Inc	12.36	$ 20.908 Millions	$ 1.691 Millions
Immucell Corporation	12.31	$ 13.028 Millions	$ 1.058 Millions
La Jolla Pharmaceutical Company	11.95	$ 19.988 Millions	$ 1.673 Millions
Zynex inc	11.84	$ 40.647 Millions	$ 3.433 Millions
Integrated Biopharma Inc	11.83	$ 51.079 Millions	$ 4.317 Millions
Arvinas Inc	11.78	$ 41.523 Millions	$ 3.526 Millions
Exact Sciences Corporation	11.75	$ 723.699 Millions	$ 61.609 Millions
The Pennant Group Inc	11.69	$ 88.398 Millions	$ 7.562 Millions
Travere Therapeutics Inc	11.61	$ 172.421 Millions	$ 14.856 Millions
Karyopharm Therapeutics Inc	11.61	$ 23.003 Millions	$ 1.982 Millions
Rigel Pharmaceuticals Inc	11.60	$ 81.745 Millions	$ 7.044 Millions
Lifeloc Technologies Inc	11.58	$ 8.715 Millions	$ 0.752 Millions
Neuronetics Inc	11.50	$ 60.935 Millions	$ 5.300 Millions
China Pharma Holdings Inc	11.09	$ 11.118 Millions	$ 1.003 Millions

Date modified: 2026-09-08T15:09:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.